ALECIA BRYNDA: Open Payments
NPI 1598004780 · LITTLETON, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,160 in 40 payments from 15 companies in 2025. Trend: 2023 $806 · 2024 $239 · 2025 $1,160
Food & beverage: $1,160
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $280 |
| GlaxoSmithKline, LLC. | 5 | $193 |
| GENZYME CORPORATION | 6 | $148 |
| Regeneron Healthcare Solutions, Inc. | 5 | $145 |
| United Therapeutics Corporation | 1 | $125 |
| SCPHARMACEUTICALS INC. | 3 | $52 |
| Merck Sharp & Dohme LLC | 2 | $43 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $27 |
| ABIOMED | 1 | $26 |
| Amgen Inc. | 1 | $24 |
Products named: DUPIXENT, NUCALA, WAINUA, FUROSCIX, SHINGRIX, TEZSPIRE, BREZTRI, Kerendia.
Industry payments across CO — which companies pay providers there.
